Brussels, 12/02/2010 (Agence Europe) - On the evening of Thursday 11 February, the European Commission approved the proposed acquisition of Solvay Pharma of Belgium by Abbott Laboratories of the USA. The decision is conditional upon the divestment of the Cystic Fibrosis testing business of Solvay Pharma's subsidiary Innogenetics in the European Economic Area (EEA).
Abbott is a global company active in pharmaceutical products, nutritional products, medical devices and diagnostics products....